Literature DB >> 22472926

Fatigue in rheumatoid arthritis: association with severity of pain, disease activity and functional status.

Yesim Garip1, Filiz Eser, Lale Akbulut Aktekin, Hatice Bodur.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic symmetric polyarthritis causing progressive joint destruction and disability. Major patient complaints are pain, disability and fatigue. The aim of this study is to assess fatigue and its association with disease-specific variables (severity of pain, disease activity, and functional status) in patients with RA. PATIENTS AND METHODS: A total of 160 RA patients were included in the study. Fatigue was measured by using Fatigue Symptom Inventory (FSI). The quadrivariate Disease Activity Score-28 (DAS28) was used for evaluating disease activity and Health Assessment Questionnaire (HAQ) for determining functional status. Severity of pain was measured by using 10 cm Visual Analog Scale-Pain (VAS-pain).
RESULTS: Intensity items of FSI (most fatigue, least fatigue, average fatigue, current fatigue) were strongly correlated with DAS28, HAQ, and VAS pain (p=0.000). When the correlation coefficients were analyzed, current fatigue showed the highest correlation with VAS-pain (r: 0.96). This was followed by DAS28 and HAQ, respectively (r: 0.77 and 0.70) (p=0.000). Duration items of FSI (number of days fatigued, amount of time fatigued) were significantly correlated with DAS28, HAQ, and VAS pain (p=0.000). Also there were significant positive correlations between interference scale of FSI and DAS28, HAQ, and VAS-pain (r: 0.68, 0.61 and 0.67, respectively) (p=0.000). None of FSI subgroups showed statistically significant correlation with di­sease duration.
CONCLUSIONS: Fatigue is strongly associated with severity of pain, disease activity and functional status. Fatigue should be included in clinical practice and clinical trials as a RA outcome measure.

Entities:  

Mesh:

Year:  2011        PMID: 22472926

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  8 in total

1.  The relationship between bristol rheumatoid arthritis fatigue scales and disease activity of patients with rheumatoid arthritis.

Authors:  Seda Colak; Sevinc Can Sandikci; Derya Gokmen; Ahmet Omma
Journal:  Clin Rheumatol       Date:  2018-07-30       Impact factor: 2.980

2.  Interplay between patient global assessment, pain, and fatigue and influence of other clinical disease activity measures in patients with active rheumatoid arthritis.

Authors:  Emilie Lund Egsmose; Ole Rintek Madsen
Journal:  Clin Rheumatol       Date:  2015-05-19       Impact factor: 2.980

Review 3.  Fatigue in chronic inflammation - a link to pain pathways.

Authors:  Karine Louati; Francis Berenbaum
Journal:  Arthritis Res Ther       Date:  2015-10-05       Impact factor: 5.156

4.  Fatigue in Egyptian patients with rheumatic diseases: a qualitative study.

Authors:  Mohamed Mortada; Amal Abdul-Sattar; Laure Gossec
Journal:  Health Qual Life Outcomes       Date:  2015-08-22       Impact factor: 3.186

5.  The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.

Authors:  Murray W Enns; Charles N Bernstein; Kristine Kroeker; Lesley Graff; John R Walker; Lisa M Lix; Carol A Hitchon; Renée El-Gabalawy; John D Fisk; Ruth Ann Marrie
Journal:  PLoS One       Date:  2018-06-07       Impact factor: 3.240

6.  A biopsychosocial network model of fatigue in rheumatoid arthritis: a systematic review.

Authors:  Rinie Geenen; Emma Dures
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

7.  Sleep, fatigue, and functional health in psychotic patients.

Authors:  Flavie Waters; Neepa Naik; Daniel Rock
Journal:  Schizophr Res Treatment       Date:  2013-04-30

8.  Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.

Authors:  Barbara Lisowska; Aleksander Lisowski; Katarzyna Siewruk
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.